The Patent Finder
US

Methods of Producing Anamorelin Hydrochloride Having Controlled Chloride Content

US 10,576,122 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 18, 2033 · High confidence

Filed Apr 14, 2019 as application 16/383,623 · Granted Mar 3, 2020
Base term, 20 years from filing
Today
20 years from filing
2013 2033
Clock starts
Apr 18, 2013
Term ends
Apr 18, 2033
Granted
Mar 3, 2020
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,300,105, US 9,403,867, US 9,872,883, US 9,956,261, US 9,981,002, to Apr 18, 2033. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
8
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 18, 2013, when application 13/865,649, the earliest non-provisional in its chain, was filed (this one was filed Apr 14, 2019)Apr 18, 2033High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,300,105, US 9,403,867, US 9,872,883, US 9,956,261, US 9,981,002)resolves to Apr 18, 2033, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderApr 18, 2033High confidence

This family

Application 13/865,649Abandoned
not computed
not computed
US 9,403,867In force
Apr 2033
Apr 2033
US 9,981,002In force
Apr 2033
Apr 2033
US 9,872,883In force
Apr 2033
Apr 2033
US 9,956,261In force
Apr 2033
Apr 2033
US 10,300,105In force
Apr 2033
Apr 2033
US 10,576,122this patent
Apr 2033
Apr 2033
US 10,905,737In force
Apr 2033
Apr 2033
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Feb 5, 2020
Reel 51718, frame 753
Kuwabe, Shin-itsu; Yanagimachi, Takehiko; Yoshiyama, Hideyuki; Pines, Seemon; De Groot, Eleanor; Garcia Rubio, Silvina; Manini, PeterHelsinn Healthcare S.A.; Ono Pharmaceutical Co., Ltd.Assignment of Assignor's Interest
Feb 5, 2020
reel/frame not recorded
Manini, Peter; Garcia Rubio, Silvina; De Groot, Eleanor; Pines, Seemon; Kuwabe, Shin-itsu; Yanagimachi, Takehiko; Yoshiyama, HideyukiHelsinn Healthcare S.A.Assignment of Assignor's Interest
Feb 5, 2020
reel/frame not recorded
Manini, Peter; Garcia Rubio, Silvina; De Groot, Eleanor; Pines, Seemon; Kuwabe, Shin-itsu; Yanagimachi, Takehiko; Yoshiyama, HideyukiOno Pharmaceutical Co., Ltd.Assignment of Assignor's Interest
Dec 30, 2022
Reel 62254, frame 888
Helsinn Healthcare S.A.; Helsinn Therapeutics (U.S.), Inc.; Helsinn Birex Pharmaceuticals LimitedHamilton S.A. LLCSecurity Interest
Sep 20, 2023
Reel 64961, frame 567
Hamilton S.A. LLCHelsinn Healthcare S.A.; Helsinn Therapeutics (U.S.), Inc.; Helsinn Birex Pharmaceuticals LimitedRelease of Security Interest
Sep 20, 2023
reel/frame not recorded
Hamilton S.A. LLCHelsinn Healthcare S.A.Release of Security Interest
Sep 20, 2023
reel/frame not recorded
Hamilton S.A. LLCHelsinn Therapeutics (U.S.), Inc.Release of Security Interest
Sep 20, 2023
reel/frame not recorded
Hamilton S.A. LLCHelsinn Birex Pharmaceuticals LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited